What does this research mean for the field?

Glycosylated carbon nanodots effectively block lectin-driven viral entry, demonstrating significant antiviral performance. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The aim is to explore the antiviral role of glycosylated carbon nanodots as blockers of viral entry via lectins.

February 22, 2026

Glycosylated Carbon Nanodots as Multivalent Blockers of Lectin-Driven Viral Entry: Structural Insights and Antiviral Performance

Key Points

The aim is to explore the antiviral role of glycosylated carbon nanodots as blockers of viral entry via lectins.
Developed glyco-CNDs using pre- and post-synthetic strategies.
Utilized one-pot synthesis for efficient creation of nanodots.
Employed click-chemistry for functionality enhancement.
Glyco-CNDs effectively blocked lectin-driven viral entry.
Structural insights confirm distinct functional classes of glyco-CNDs.
Demonstrated antiviral activity suggests potential for further development.

Abstract

A versatile nanoplatform of glycosilated carbon nanodots (glyco-CNDs) has been developed using combined pre- and post-synthetic strategies. By combining one-pot synthesis and click-chemistry functionalization, three classes of glyco-CNDs displaying distinct...

Bookmark

View Full Paper

Bookmark

View Full Paper

Glycosylated Carbon Nanodots as Multivalent Blockers of Lectin-Driven Viral Entry: Structural Insights and Antiviral Performance

Key Points

Abstract

Cite This Study